Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: pancreatic neuroendocrine tumors
FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer
The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs). pNETs is a rare, slow-growing form of pancreatic cancer. In theUnited States, there are fewer than 1000 new pNET cases … Continue reading
Posted in Cancer, Pancreatic Cancer
Tagged advanced renal cell carcinoma, Afinitor, Everolimus, FDA, mTOR, Nexavar, pancreatic neuroendocrine tumors, pNETs, RADIAN-3, sorafenib, subependymal giant cell astrocytoma, sunitinib, Sutent, tuberous sclerosis
Comments Off on FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer
